White House Announces 50-State Medicaid Drug Pricing Initiative
President Trump will announce that all 50 states will implement "most favored nation" pricing for certain Medicaid-covered drugs, according to an administration official. The announcement, scheduled for Friday with several governors present, would tie Medicaid drug prices to lower international reference prices. Implementation details including which drugs are covered, effective dates, and how this aligns with existing Medicaid best price and rebate requirements remain unclear. The initiative reflects ongoing White House focus on drug affordability as a voter priority.
MFN pricing could fundamentally alter Medicaid pharmacy costs and rebate calculations, potentially affecting state budgets, supplemental rebate agreements, and MCO drug spending — though enforceability and interaction with federal rebate statute are uncertain.
Pharmacy · Managed Care · Finance
You might also like